Pharma & Healthcare
Global Pneumococcal Bacteria Vaccine Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4288
- Pages: 91
- Figures: 112
- Views: 22
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
The global Pneumococcal Bacteria Vaccine market is projected to grow from US$ 7485.3 million in 2024 to US$ 9692 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Pneumococcal Bacteria Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pneumococcal Bacteria Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pneumococcal Bacteria Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pneumococcal Bacteria Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Bacteria Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Bacteria Vaccine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Sinopharm
Pfizer
Walvax
GSK
Segment by Type
PPSV 23
PCV 13
PCV 10
Segment by Application
Infant
Children
Adult
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pneumococcal Bacteria Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pneumococcal Bacteria Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumococcal Bacteria Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Pneumococcal Bacteria Vaccine market is projected to grow from US$ 7485.3 million in 2024 to US$ 9692 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Pneumococcal Bacteria Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pneumococcal Bacteria Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pneumococcal Bacteria Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pneumococcal Bacteria Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Bacteria Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Bacteria Vaccine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Sinopharm
Pfizer
Walvax
GSK
Segment by Type
PPSV 23
PCV 13
PCV 10
Segment by Application
Infant
Children
Adult
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pneumococcal Bacteria Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pneumococcal Bacteria Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumococcal Bacteria Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Pneumococcal Bacteria Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PPSV 23
1.2.3 PCV 13
1.2.4 PCV 10
1.3 Market by Application
1.3.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Infant
1.3.3 Children
1.3.4 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Pneumococcal Bacteria Vaccine Revenue by Region
2.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pneumococcal Bacteria Vaccine Revenue by Region (2019-2024)
2.2.3 Global Pneumococcal Bacteria Vaccine Revenue by Region (2025-2030)
2.2.4 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2019-2030)
2.3 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Pneumococcal Bacteria Vaccine Sales by Region
2.4.1 Global Pneumococcal Bacteria Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pneumococcal Bacteria Vaccine Sales by Region (2019-2024)
2.4.3 Global Pneumococcal Bacteria Vaccine Sales by Region (2025-2030)
2.4.4 Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers
3.1.1 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pneumococcal Bacteria Vaccine in 2023
3.2 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers
3.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pneumococcal Bacteria Vaccine Revenue in 2023
3.3 Global Key Players of Pneumococcal Bacteria Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pneumococcal Bacteria Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pneumococcal Bacteria Vaccine Sales by Type
4.1.1 Global Pneumococcal Bacteria Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Pneumococcal Bacteria Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pneumococcal Bacteria Vaccine Revenue by Type
4.2.1 Global Pneumococcal Bacteria Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Pneumococcal Bacteria Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pneumococcal Bacteria Vaccine Price by Type
4.3.1 Global Pneumococcal Bacteria Vaccine Price by Type (2019-2024)
4.3.2 Global Pneumococcal Bacteria Vaccine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pneumococcal Bacteria Vaccine Sales by Application
5.1.1 Global Pneumococcal Bacteria Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Pneumococcal Bacteria Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pneumococcal Bacteria Vaccine Revenue by Application
5.2.1 Global Pneumococcal Bacteria Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Pneumococcal Bacteria Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pneumococcal Bacteria Vaccine Price by Application
5.3.1 Global Pneumococcal Bacteria Vaccine Price by Application (2019-2024)
5.3.2 Global Pneumococcal Bacteria Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pneumococcal Bacteria Vaccine Market Size by Type
6.1.1 US & Canada Pneumococcal Bacteria Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Pneumococcal Bacteria Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Pneumococcal Bacteria Vaccine Market Size by Application
6.2.1 US & Canada Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Pneumococcal Bacteria Vaccine Market Size by Country
6.3.1 US & Canada Pneumococcal Bacteria Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pneumococcal Bacteria Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Pneumococcal Bacteria Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pneumococcal Bacteria Vaccine Market Size by Type
7.1.1 Europe Pneumococcal Bacteria Vaccine Sales by Type (2019-2030)
7.1.2 Europe Pneumococcal Bacteria Vaccine Revenue by Type (2019-2030)
7.2 Europe Pneumococcal Bacteria Vaccine Market Size by Application
7.2.1 Europe Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
7.2.2 Europe Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
7.3 Europe Pneumococcal Bacteria Vaccine Market Size by Country
7.3.1 Europe Pneumococcal Bacteria Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pneumococcal Bacteria Vaccine Sales by Country (2019-2030)
7.3.3 Europe Pneumococcal Bacteria Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pneumococcal Bacteria Vaccine Market Size
8.1.1 China Pneumococcal Bacteria Vaccine Sales (2019-2030)
8.1.2 China Pneumococcal Bacteria Vaccine Revenue (2019-2030)
8.2 China Pneumococcal Bacteria Vaccine Market Size by Application
8.2.1 China Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
8.2.2 China Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pneumococcal Bacteria Vaccine Market Size by Type
9.1.1 Asia Pneumococcal Bacteria Vaccine Sales by Type (2019-2030)
9.1.2 Asia Pneumococcal Bacteria Vaccine Revenue by Type (2019-2030)
9.2 Asia Pneumococcal Bacteria Vaccine Market Size by Application
9.2.1 Asia Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
9.2.2 Asia Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
9.3 Asia Pneumococcal Bacteria Vaccine Sales by Region
9.3.1 Asia Pneumococcal Bacteria Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pneumococcal Bacteria Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Pneumococcal Bacteria Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Sanofi Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Sinopharm
11.3.1 Sinopharm Company Information
11.3.2 Sinopharm Overview
11.3.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sinopharm Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sinopharm Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Pfizer Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Walvax
11.5.1 Walvax Company Information
11.5.2 Walvax Overview
11.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Walvax Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Walvax Recent Developments
11.6 GSK
11.6.1 GSK Company Information
11.6.2 GSK Overview
11.6.3 GSK Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 GSK Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pneumococcal Bacteria Vaccine Industry Chain Analysis
12.2 Pneumococcal Bacteria Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pneumococcal Bacteria Vaccine Production Mode & Process
12.4 Pneumococcal Bacteria Vaccine Sales and Marketing
12.4.1 Pneumococcal Bacteria Vaccine Sales Channels
12.4.2 Pneumococcal Bacteria Vaccine Distributors
12.5 Pneumococcal Bacteria Vaccine Customers
13 Market Dynamics
13.1 Pneumococcal Bacteria Vaccine Industry Trends
13.2 Pneumococcal Bacteria Vaccine Market Drivers
13.3 Pneumococcal Bacteria Vaccine Market Challenges
13.4 Pneumococcal Bacteria Vaccine Market Restraints
14 Key Findings in The Global Pneumococcal Bacteria Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Pneumococcal Bacteria Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PPSV 23
1.2.3 PCV 13
1.2.4 PCV 10
1.3 Market by Application
1.3.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Infant
1.3.3 Children
1.3.4 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Pneumococcal Bacteria Vaccine Revenue by Region
2.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pneumococcal Bacteria Vaccine Revenue by Region (2019-2024)
2.2.3 Global Pneumococcal Bacteria Vaccine Revenue by Region (2025-2030)
2.2.4 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2019-2030)
2.3 Global Pneumococcal Bacteria Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Pneumococcal Bacteria Vaccine Sales by Region
2.4.1 Global Pneumococcal Bacteria Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pneumococcal Bacteria Vaccine Sales by Region (2019-2024)
2.4.3 Global Pneumococcal Bacteria Vaccine Sales by Region (2025-2030)
2.4.4 Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers
3.1.1 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pneumococcal Bacteria Vaccine in 2023
3.2 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers
3.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pneumococcal Bacteria Vaccine Revenue in 2023
3.3 Global Key Players of Pneumococcal Bacteria Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pneumococcal Bacteria Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pneumococcal Bacteria Vaccine Sales by Type
4.1.1 Global Pneumococcal Bacteria Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Pneumococcal Bacteria Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pneumococcal Bacteria Vaccine Revenue by Type
4.2.1 Global Pneumococcal Bacteria Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Pneumococcal Bacteria Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pneumococcal Bacteria Vaccine Price by Type
4.3.1 Global Pneumococcal Bacteria Vaccine Price by Type (2019-2024)
4.3.2 Global Pneumococcal Bacteria Vaccine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pneumococcal Bacteria Vaccine Sales by Application
5.1.1 Global Pneumococcal Bacteria Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Pneumococcal Bacteria Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pneumococcal Bacteria Vaccine Revenue by Application
5.2.1 Global Pneumococcal Bacteria Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Pneumococcal Bacteria Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pneumococcal Bacteria Vaccine Price by Application
5.3.1 Global Pneumococcal Bacteria Vaccine Price by Application (2019-2024)
5.3.2 Global Pneumococcal Bacteria Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pneumococcal Bacteria Vaccine Market Size by Type
6.1.1 US & Canada Pneumococcal Bacteria Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Pneumococcal Bacteria Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Pneumococcal Bacteria Vaccine Market Size by Application
6.2.1 US & Canada Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Pneumococcal Bacteria Vaccine Market Size by Country
6.3.1 US & Canada Pneumococcal Bacteria Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pneumococcal Bacteria Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Pneumococcal Bacteria Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pneumococcal Bacteria Vaccine Market Size by Type
7.1.1 Europe Pneumococcal Bacteria Vaccine Sales by Type (2019-2030)
7.1.2 Europe Pneumococcal Bacteria Vaccine Revenue by Type (2019-2030)
7.2 Europe Pneumococcal Bacteria Vaccine Market Size by Application
7.2.1 Europe Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
7.2.2 Europe Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
7.3 Europe Pneumococcal Bacteria Vaccine Market Size by Country
7.3.1 Europe Pneumococcal Bacteria Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pneumococcal Bacteria Vaccine Sales by Country (2019-2030)
7.3.3 Europe Pneumococcal Bacteria Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pneumococcal Bacteria Vaccine Market Size
8.1.1 China Pneumococcal Bacteria Vaccine Sales (2019-2030)
8.1.2 China Pneumococcal Bacteria Vaccine Revenue (2019-2030)
8.2 China Pneumococcal Bacteria Vaccine Market Size by Application
8.2.1 China Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
8.2.2 China Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pneumococcal Bacteria Vaccine Market Size by Type
9.1.1 Asia Pneumococcal Bacteria Vaccine Sales by Type (2019-2030)
9.1.2 Asia Pneumococcal Bacteria Vaccine Revenue by Type (2019-2030)
9.2 Asia Pneumococcal Bacteria Vaccine Market Size by Application
9.2.1 Asia Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
9.2.2 Asia Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
9.3 Asia Pneumococcal Bacteria Vaccine Sales by Region
9.3.1 Asia Pneumococcal Bacteria Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pneumococcal Bacteria Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Pneumococcal Bacteria Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Sanofi Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Sinopharm
11.3.1 Sinopharm Company Information
11.3.2 Sinopharm Overview
11.3.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sinopharm Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sinopharm Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Pfizer Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Walvax
11.5.1 Walvax Company Information
11.5.2 Walvax Overview
11.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Walvax Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Walvax Recent Developments
11.6 GSK
11.6.1 GSK Company Information
11.6.2 GSK Overview
11.6.3 GSK Pneumococcal Bacteria Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 GSK Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pneumococcal Bacteria Vaccine Industry Chain Analysis
12.2 Pneumococcal Bacteria Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pneumococcal Bacteria Vaccine Production Mode & Process
12.4 Pneumococcal Bacteria Vaccine Sales and Marketing
12.4.1 Pneumococcal Bacteria Vaccine Sales Channels
12.4.2 Pneumococcal Bacteria Vaccine Distributors
12.5 Pneumococcal Bacteria Vaccine Customers
13 Market Dynamics
13.1 Pneumococcal Bacteria Vaccine Industry Trends
13.2 Pneumococcal Bacteria Vaccine Market Drivers
13.3 Pneumococcal Bacteria Vaccine Market Challenges
13.4 Pneumococcal Bacteria Vaccine Market Restraints
14 Key Findings in The Global Pneumococcal Bacteria Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of PPSV 23
Table 3. Major Manufacturers of PCV 13
Table 4. Major Manufacturers of PCV 10
Table 5. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Pneumococcal Bacteria Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Pneumococcal Bacteria Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2019-2024)
Table 10. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2025-2030)
Table 11. Global Pneumococcal Bacteria Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Pneumococcal Bacteria Vaccine Sales by Region (2019-2024) & (K Units)
Table 13. Global Pneumococcal Bacteria Vaccine Sales by Region (2025-2030) & (K Units)
Table 14. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2019-2024)
Table 15. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2025-2030)
Table 16. Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2019-2024) & (K Units)
Table 17. Global Pneumococcal Bacteria Vaccine Sales Share by Manufacturers (2019-2024)
Table 18. Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Pneumococcal Bacteria Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Pneumococcal Bacteria Vaccine Price by Manufacturers 2019-2024 (US$/Unit)
Table 22. Global Pneumococcal Bacteria Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Pneumococcal Bacteria Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Bacteria Vaccine as of 2023)
Table 24. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 29. Global Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 30. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2019-2024)
Table 31. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2025-2030)
Table 32. Global Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2019-2024)
Table 35. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2025-2030)
Table 36. Pneumococcal Bacteria Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 37. Global Pneumococcal Bacteria Vaccine Price Forecast by Type (2025-2030) & (US$/Unit)
Table 38. Global Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. Global Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 40. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2019-2024)
Table 41. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2025-2030)
Table 42. Global Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2019-2024)
Table 45. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2025-2030)
Table 46. Pneumococcal Bacteria Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 47. Global Pneumococcal Bacteria Vaccine Price Forecast by Application (2025-2030) & (US$/Unit)
Table 48. US & Canada Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 49. US & Canada Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 50. US & Canada Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 53. US & Canada Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 54. US & Canada Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Pneumococcal Bacteria Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Pneumococcal Bacteria Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Pneumococcal Bacteria Vaccine Sales by Country (2019-2024) & (K Units)
Table 60. US & Canada Pneumococcal Bacteria Vaccine Sales by Country (2025-2030) & (K Units)
Table 61. Europe Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 62. Europe Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 63. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 66. Europe Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 67. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Pneumococcal Bacteria Vaccine Sales by Country (2019-2024) & (K Units)
Table 73. Europe Pneumococcal Bacteria Vaccine Sales by Country (2025-2030) & (K Units)
Table 74. China Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 75. China Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 76. China Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 79. China Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 80. China Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 81. China Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 83. Asia Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 84. Asia Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 87. Asia Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 88. Asia Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Pneumococcal Bacteria Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Pneumococcal Bacteria Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Pneumococcal Bacteria Vaccine Sales by Region (2019-2024) & (K Units)
Table 94. Asia Pneumococcal Bacteria Vaccine Sales by Region (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Country (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Country (2025-2030) & (K Units)
Table 108. Merck Company Information
Table 109. Merck Description and Major Businesses
Table 110. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Merck Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Merck Recent Developments
Table 113. Sanofi Company Information
Table 114. Sanofi Description and Major Businesses
Table 115. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sanofi Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sanofi Recent Developments
Table 118. Sinopharm Company Information
Table 119. Sinopharm Description and Major Businesses
Table 120. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Sinopharm Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Sinopharm Recent Developments
Table 123. Pfizer Company Information
Table 124. Pfizer Description and Major Businesses
Table 125. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Pfizer Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Pfizer Recent Developments
Table 128. Walvax Company Information
Table 129. Walvax Description and Major Businesses
Table 130. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Walvax Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Walvax Recent Developments
Table 133. GSK Company Information
Table 134. GSK Description and Major Businesses
Table 135. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. GSK Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. GSK Recent Developments
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Pneumococcal Bacteria Vaccine Distributors List
Table 141. Pneumococcal Bacteria Vaccine Customers List
Table 142. Pneumococcal Bacteria Vaccine Market Trends
Table 143. Pneumococcal Bacteria Vaccine Market Drivers
Table 144. Pneumococcal Bacteria Vaccine Market Challenges
Table 145. Pneumococcal Bacteria Vaccine Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Bacteria Vaccine Product Picture
Figure 2. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pneumococcal Bacteria Vaccine Market Share by Type in 2023 & 2030
Figure 4. PPSV 23 Product Picture
Figure 5. PCV 13 Product Picture
Figure 6. PCV 10 Product Picture
Figure 7. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Pneumococcal Bacteria Vaccine Market Share by Application in 2023 & 2030
Figure 9. Infant
Figure 10. Children
Figure 11. Adult
Figure 12. Pneumococcal Bacteria Vaccine Report Years Considered
Figure 13. Global Pneumococcal Bacteria Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pneumococcal Bacteria Vaccine Revenue 2019-2030 (US$ Million)
Figure 15. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2019-2030)
Figure 17. Global Pneumococcal Bacteria Vaccine Sales 2019-2030 ((K Units)
Figure 18. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 24. China Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Pneumococcal Bacteria Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Pneumococcal Bacteria Vaccine in the World: Market Share by Pneumococcal Bacteria Vaccine Revenue in 2023
Figure 31. Global Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 33. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 34. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 35. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Pneumococcal Bacteria Vaccine Revenue Share by Country (2019-2030)
Figure 41. US & Canada Pneumococcal Bacteria Vaccine Sales Share by Country (2019-2030)
Figure 42. U.S. Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 45. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 46. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 47. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 48. Europe Pneumococcal Bacteria Vaccine Revenue Share by Country (2019-2030)
Figure 49. Europe Pneumococcal Bacteria Vaccine Sales Share by Country (2019-2030)
Figure 50. Germany Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 51. France Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 55. China Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 56. China Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 57. China Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 58. China Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 59. Asia Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 60. Asia Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 61. Asia Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 62. Asia Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 63. Asia Pneumococcal Bacteria Vaccine Revenue Share by Region (2019-2030)
Figure 64. Asia Pneumococcal Bacteria Vaccine Sales Share by Region (2019-2030)
Figure 65. Japan Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 69. India Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales Share by Country (2019-2030)
Figure 76. Brazil Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 81. Pneumococcal Bacteria Vaccine Value Chain
Figure 82. Pneumococcal Bacteria Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Table 1. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of PPSV 23
Table 3. Major Manufacturers of PCV 13
Table 4. Major Manufacturers of PCV 10
Table 5. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Pneumococcal Bacteria Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Pneumococcal Bacteria Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2019-2024)
Table 10. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2025-2030)
Table 11. Global Pneumococcal Bacteria Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Pneumococcal Bacteria Vaccine Sales by Region (2019-2024) & (K Units)
Table 13. Global Pneumococcal Bacteria Vaccine Sales by Region (2025-2030) & (K Units)
Table 14. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2019-2024)
Table 15. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2025-2030)
Table 16. Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2019-2024) & (K Units)
Table 17. Global Pneumococcal Bacteria Vaccine Sales Share by Manufacturers (2019-2024)
Table 18. Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Pneumococcal Bacteria Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Pneumococcal Bacteria Vaccine Price by Manufacturers 2019-2024 (US$/Unit)
Table 22. Global Pneumococcal Bacteria Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Pneumococcal Bacteria Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Bacteria Vaccine as of 2023)
Table 24. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Pneumococcal Bacteria Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 29. Global Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 30. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2019-2024)
Table 31. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2025-2030)
Table 32. Global Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2019-2024)
Table 35. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2025-2030)
Table 36. Pneumococcal Bacteria Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 37. Global Pneumococcal Bacteria Vaccine Price Forecast by Type (2025-2030) & (US$/Unit)
Table 38. Global Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. Global Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 40. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2019-2024)
Table 41. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2025-2030)
Table 42. Global Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2019-2024)
Table 45. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2025-2030)
Table 46. Pneumococcal Bacteria Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 47. Global Pneumococcal Bacteria Vaccine Price Forecast by Application (2025-2030) & (US$/Unit)
Table 48. US & Canada Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 49. US & Canada Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 50. US & Canada Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 53. US & Canada Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 54. US & Canada Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Pneumococcal Bacteria Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Pneumococcal Bacteria Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Pneumococcal Bacteria Vaccine Sales by Country (2019-2024) & (K Units)
Table 60. US & Canada Pneumococcal Bacteria Vaccine Sales by Country (2025-2030) & (K Units)
Table 61. Europe Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 62. Europe Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 63. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 66. Europe Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 67. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Pneumococcal Bacteria Vaccine Sales by Country (2019-2024) & (K Units)
Table 73. Europe Pneumococcal Bacteria Vaccine Sales by Country (2025-2030) & (K Units)
Table 74. China Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 75. China Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 76. China Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 79. China Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 80. China Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 81. China Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 83. Asia Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 84. Asia Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 87. Asia Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 88. Asia Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Pneumococcal Bacteria Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Pneumococcal Bacteria Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Pneumococcal Bacteria Vaccine Sales by Region (2019-2024) & (K Units)
Table 94. Asia Pneumococcal Bacteria Vaccine Sales by Region (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Type (2019-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Type (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Application (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Application (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Country (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales by Country (2025-2030) & (K Units)
Table 108. Merck Company Information
Table 109. Merck Description and Major Businesses
Table 110. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Merck Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Merck Recent Developments
Table 113. Sanofi Company Information
Table 114. Sanofi Description and Major Businesses
Table 115. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Sanofi Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sanofi Recent Developments
Table 118. Sinopharm Company Information
Table 119. Sinopharm Description and Major Businesses
Table 120. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Sinopharm Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Sinopharm Recent Developments
Table 123. Pfizer Company Information
Table 124. Pfizer Description and Major Businesses
Table 125. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Pfizer Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Pfizer Recent Developments
Table 128. Walvax Company Information
Table 129. Walvax Description and Major Businesses
Table 130. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Walvax Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Walvax Recent Developments
Table 133. GSK Company Information
Table 134. GSK Description and Major Businesses
Table 135. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. GSK Pneumococcal Bacteria Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. GSK Recent Developments
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Pneumococcal Bacteria Vaccine Distributors List
Table 141. Pneumococcal Bacteria Vaccine Customers List
Table 142. Pneumococcal Bacteria Vaccine Market Trends
Table 143. Pneumococcal Bacteria Vaccine Market Drivers
Table 144. Pneumococcal Bacteria Vaccine Market Challenges
Table 145. Pneumococcal Bacteria Vaccine Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Bacteria Vaccine Product Picture
Figure 2. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pneumococcal Bacteria Vaccine Market Share by Type in 2023 & 2030
Figure 4. PPSV 23 Product Picture
Figure 5. PCV 13 Product Picture
Figure 6. PCV 10 Product Picture
Figure 7. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Pneumococcal Bacteria Vaccine Market Share by Application in 2023 & 2030
Figure 9. Infant
Figure 10. Children
Figure 11. Adult
Figure 12. Pneumococcal Bacteria Vaccine Report Years Considered
Figure 13. Global Pneumococcal Bacteria Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pneumococcal Bacteria Vaccine Revenue 2019-2030 (US$ Million)
Figure 15. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2019-2030)
Figure 17. Global Pneumococcal Bacteria Vaccine Sales 2019-2030 ((K Units)
Figure 18. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 24. China Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Pneumococcal Bacteria Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Pneumococcal Bacteria Vaccine in the World: Market Share by Pneumococcal Bacteria Vaccine Revenue in 2023
Figure 31. Global Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 33. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 34. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 35. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Pneumococcal Bacteria Vaccine Revenue Share by Country (2019-2030)
Figure 41. US & Canada Pneumococcal Bacteria Vaccine Sales Share by Country (2019-2030)
Figure 42. U.S. Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 45. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 46. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 47. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 48. Europe Pneumococcal Bacteria Vaccine Revenue Share by Country (2019-2030)
Figure 49. Europe Pneumococcal Bacteria Vaccine Sales Share by Country (2019-2030)
Figure 50. Germany Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 51. France Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 55. China Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 56. China Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 57. China Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 58. China Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 59. Asia Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 60. Asia Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 61. Asia Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 62. Asia Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 63. Asia Pneumococcal Bacteria Vaccine Revenue Share by Region (2019-2030)
Figure 64. Asia Pneumococcal Bacteria Vaccine Sales Share by Region (2019-2030)
Figure 65. Japan Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 69. India Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Pneumococcal Bacteria Vaccine Sales Share by Country (2019-2030)
Figure 76. Brazil Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Pneumococcal Bacteria Vaccine Revenue (2019-2030) & (US$ Million)
Figure 81. Pneumococcal Bacteria Vaccine Value Chain
Figure 82. Pneumococcal Bacteria Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232